1. Liver and gastrointestinal cancers
    Jose J.G. Marin et al, 2020, Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy CrossRef
  2. Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
    Pin Zhao et al, 2021, Frontiers in Oncology CrossRef
  3. THUMP domain containing 2 protein possibly induces resistance to cisplatin and 5‐fluorouracil in in vitro human esophageal squamous cell carcinoma cells as revealed by transposon activation mutagenesis
    Masato Hayashi et al, 2019, The Journal of Gene Medicine CrossRef
  4. SDC1 promotes cisplatin resistance in hepatic carcinoma cells via PI3K-AKT pathway
    Liquan Yu et al, 2020, Human Cell CrossRef
  5. Multiple Roles of the RUNX Gene Family in Hepatocellular Carcinoma and Their Potential Clinical Implications
    Milena Krajnović et al, 2023, Cells CrossRef
  6. Exosome miR‐335 as a novel therapeutic strategy in hepatocellular carcinoma
    Fang Wang et al, 2018, Hepatology CrossRef

  7. Regulation of RUNX3 Expression by DNA Methylation in Prostate Cancer


    Xin Yang et al, 2020, Cancer Management and Research CrossRef
  8. miR-186 reverses cisplatin resistance and inhibits the�formation of the glioblastoma-initiating cell�phenotype by degrading Yin Yang 1 in glioblastoma
    Jian Li et al, 2018, International Journal of Molecular Medicine CrossRef
  9. Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer
    Mathieu Chocry et al, 2022, Cancers CrossRef
  10. Serum glycine dehydrogenase is associated with increased risk of lung cancer and promotes malignant transformation by regulating DNA methyltransferases expression
    Hai‑Yan Wei et al, 2018, Molecular Medicine Reports CrossRef
  11. miR‐106b‐5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3
    Hao Gu et al, 2019, Cancer Medicine CrossRef
  12. Cisplatin resistance‑associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma
    Shuping Zhou et al, 2020, Experimental and Therapeutic Medicine CrossRef
  13. Molecular subtypes of disulfidptosis-regulated genes and prognosis models for predicting prognosis, tumor microenvironment infiltration, and therapeutic response in hepatocellular carcinoma
    Jialin Qu et al, 2024, International Journal of Biological Macromolecules CrossRef